SQZ Biotechnologies stock analysis
SQZ Biotechnologies (SQZB) Stock Price & Analysis
SQZB Stock Chart & Stats
- Day’s Range
- $0.02 - $0.02
- 52-Week Range
- $0.01 - $0.05
- Previous Close
- $0.02
- Volume
- N/A
- Average Volume (3M)
- 41.71K
- Market Cap
- $707.79K
- Enterprise Value
- $13.65M
- Total Cash (Recent Filing)
- $10.19M
- Total Debt (Recent Filing)
- $21.47M
- Price to Earnings (P/E)
- ―
- Beta
- 0.42
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
SQZB FAQ
What was SQZ Biotechnologies’s price range in the past 12 months?
What is SQZ Biotechnologies’s market cap?
When is SQZ Biotechnologies’s upcoming earnings report date?
How were SQZ Biotechnologies’s earnings last quarter?
Is SQZ Biotechnologies overvalued?
Does SQZ Biotechnologies pay dividends?
What is SQZ Biotechnologies’s EPS estimate?
How many shares outstanding does SQZ Biotechnologies have?
What happened to SQZ Biotechnologies’s price movement after its last earnings report?
Which hedge fund is a major shareholder of SQZ Biotechnologies?
What is the TipRanks Smart Score and how is it calculated?
Company Description
SQZ Biotechnologies
SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, infectious diseases, and other serious conditions in Massachusetts. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV and SQZ-eAPC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Howard Bernstein
- Employees
- 53
- Website
- www.sqzbiotech.com
- Address
- 200 Arsenal Yards Boulevard, Watertown, MA, 02472, US
SQZ Biotechnologies (SQZB) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 5 | 5 | 11 |
| Technical Analysis | 3 | 3 | 3 |
| Moving Averages | 2 | 2 | 8 |

